India's Lyka Labs secures drug patent for diabetes-related conditions; shares surge

Lyka Labs

08/04/2025 07:44

** Shares of Lyka Labs LYKA.NS rise as much as 11.4% to 112.84 rupees amid broader market rebound

** Benchmark Nifty 50 .NSEI up 1.6%

** Stock had dropped 5.3% in the last two sessions tracking broader market sell-off triggered by Trump tariffs

** Drugmaker secures Indian patent for Pregabalin Gel 8%; used for the management of diabetic neuropathic pain

** Co did not give details on the financial gain from the patent

** Stock last up 5.8%, cutting YTD loss to 32.2%

(Reporting by Ashish Chandra in Bengaluru)

((ashish.chandra@thomsonreuters.com (+91 7982114624)))